Clinical Trial Update: Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stem cell therapy for medically refractory Crohn's colitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Crohn Colitis | Phase 1, Phase 2 | Status: TERMINATED